Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement

By sjmartinez • May 4, 2025

Leboulleux S, Boucai L, Busaidy N, Durante C, Fagin JA, Fazeli S, Gianoukakis AG, Haugen BR, Kang H, Konda B, Laetsch TW, Locati L, Ryder M, Spitzweg C, Worden FP, Wirth L, Ho A. Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement. Lancet Diabetes Endocrinol. 2025 Apr 30:S2213-8587(25)00064-6. doi: 10.1016/S2213-8587(25)00064-6. Epub ahead of print. PMID: 40318680.

Tags: Endocrinology, Harbor UCLA, Publications

Markers of mitochondrial function and oxidative metabolism in skeletal muscle do not display intrinsic circadian regulation in female mice

Fitzgerald LS, Reynoso Spurrier CS, Lau N, Melamed M, Burnett LA, Meyer GA, Gui C, Hevener AL, Sanford JA, Schenk S. Markers of mitochondrial function[...]

TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and Parkin-independent mitophagy

Levi-D'Ancona E, Walker EM, Zhu J, Deng Y, Sidarala V, Stendahl AM, Reck EC, Henry-Kanarek BA, Lietzke AC, Chai B, Pasmooij MB, Hubers DL, Basrur[...]

Late Diagnosis of Pregnancy in a Transmasculine Patient on Testosterone: A Case Report and Patient Perspective

Agrawal N, Kanin M, Binder HL, Havard A, Grock S. Late Diagnosis of Pregnancy in a Transmasculine Patient on Testosterone: A Case Report and Patient[...]